Skip to main content

Triamcinolone Acetonide Intravitreal Injection

Last Updated: November 28, 2022
Status: Current

Products Affected - Description
    • Triesence intravitreal suspension for injection, Novartis, 40 mg/mL, 1 mL vial, NDC 00065-0543-01
Reason for the Shortage
    • Novartis did not provide a reason for the shortage.
Available Products
    • There are no presentations available

Estimated Resupply Dates

    • Novartis has Triesence 40 mg/mL 1 mL vials on back order and the company estimates a release date of 2nd quarter 2023.


Updated November 28, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 30, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.